Mitochondrial disease
- PMID: 16815381
- DOI: 10.1016/S0140-6736(06)68970-8
Mitochondrial disease
Abstract
Defects of mitochondrial metabolism cause a wide range of human diseases that include examples from all medical subspecialties. This review updates the topic of mitochondrial diseases by reviewing the most important recent advances in this area. The factors influencing inheritance, maintenance and replication of mtDNA are reviewed and the genotype-phenotype of mtDNA disorders has been expanded, with new insights into epidemiology, pathogenesis and its role in ageing. Recently identified nuclear gene mutations of mitochondrial proteins include mutations of frataxin causing Friedreich's ataxia, PINK1, DJ1 causing Parkinson's disease and POLG causing infantile mtDNA depletion syndrome, ophthalmoplegia, parkinsonism, male subfertility and, in a transgenic mouse model, premature senescence. Mitochondrial defects in neurodegenerative diseases include Parkinson's, Alzheimer's and Huntington's disease. Improved understanding of mtDNA inheritance and mutation penetrance patterns, and novel techniques for mtDNA modification offer significant prospects for more accurate genetic counselling and effective future therapies.
Similar articles
-
Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.J Neurol Sci. 2005 Jun 15;233(1-2):145-62. doi: 10.1016/j.jns.2005.03.012. J Neurol Sci. 2005. PMID: 15896810 Review.
-
Mitochondrial disorders.Curr Opin Neurol. 2007 Oct;20(5):564-71. doi: 10.1097/WCO.0b013e3282ef58cd. Curr Opin Neurol. 2007. PMID: 17885446 Review.
-
Mesencephalic complex I deficiency does not correlate with parkinsonism in mitochondrial DNA maintenance disorders.Brain. 2013 Aug;136(Pt 8):2379-92. doi: 10.1093/brain/awt160. Epub 2013 Jun 27. Brain. 2013. PMID: 23811324
-
Depletion of the other genome-mitochondrial DNA depletion syndromes in humans.J Mol Med (Berl). 2002 Jul;80(7):389-96. doi: 10.1007/s00109-002-0343-5. Epub 2002 May 24. J Mol Med (Berl). 2002. PMID: 12110944
-
Mitochondrial DNA polymerase-gamma and human disease.Hum Mol Genet. 2006 Oct 15;15 Spec No 2:R244-52. doi: 10.1093/hmg/ddl233. Hum Mol Genet. 2006. PMID: 16987890 Review.
Cited by
-
Drug Target to Alleviate Mitochondrial Dysfunctions in Alzheimer's Disease: Recent Advances and Therapeutic Implications.Curr Neuropharmacol. 2024;22(12):1942-1959. doi: 10.2174/1570159X22666240426091311. Curr Neuropharmacol. 2024. PMID: 39234772 Free PMC article. Review.
-
Role of Nitric Oxide Modulators in Neuroprotective Effects of Mangiferin in 6-Hydroxydopamine-induced Parkinson's Disease in Rats.Ann Neurosci. 2024 Jul;31(3):186-203. doi: 10.1177/09727531231184698. Epub 2023 Aug 23. Ann Neurosci. 2024. PMID: 39156628 Free PMC article.
-
The interplay between mitochondria, the gut microbiome and metabolites and their therapeutic potential in primary mitochondrial disease.Front Pharmacol. 2024 Jul 25;15:1428242. doi: 10.3389/fphar.2024.1428242. eCollection 2024. Front Pharmacol. 2024. PMID: 39119601 Free PMC article. Review.
-
Leigh Syndrome due to MT-ATP6 Variants: A Case Presentation and the Review of the Literature.Mol Syndromol. 2024 Aug;15(4):333-338. doi: 10.1159/000536676. Epub 2024 Mar 4. Mol Syndromol. 2024. PMID: 39119452
-
Leber's hereditary optic neuropathy: Update on current diagnosis and treatment.Front Ophthalmol (Lausanne). 2023 Jan 11;2:1077395. doi: 10.3389/fopht.2022.1077395. eCollection 2022. Front Ophthalmol (Lausanne). 2023. PMID: 38983564 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical